Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

Completed
Has Results
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, Non-Hodgkin
  • brentuximab vedotin
  • Birmingham, Alabama
  • +21 more
Feb 2, 2017

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)

Completed
Has Results
  • Disease, Hodgkin
  • +2 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +16 more
Dec 7, 2016

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

Completed
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Birmingham, Alabama
  • +33 more
Oct 14, 2016

Leukemia, Cancer, Lymphoma Trial in Houston (Ara C, Mesna, Cyclophosphamide)

Terminated
Has Results
  • Leukemia
  • +4 more
  • Ara C
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Mar 24, 2016

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +65 more
Feb 6, 2015

Lymphoma, Non-Hodgkin, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (SGN-35)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +3 more
Dec 17, 2014

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in United States (SGN-35, gemcitabine)

Terminated
  • Disease, Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +4 more
Dec 17, 2014

Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

Completed
  • Carcinoma, Renal Cell
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia Trial in United States (CNTO 328)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • CNTO 328
  • Little Rock, Arkansas
  • +8 more
Jun 30, 2014

Lymphoma, Non-Hodgkin Trial in Canada, United States (Granulocyte colony-stimulating factor plus plerixafor, Granulocyte

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Granulocyte colony-stimulating factor plus plerixafor
  • Granulocyte colony-stimulating factor plus placebo
  • Phoenix, Arizona
  • +31 more
Feb 10, 2014

Lymphoma, Non-Hodgkin Trial in United States (TRAIL-R1 mAb (TRM-1; HGS-ETR1))

Completed
  • Lymphoma, Non-Hodgkin
  • TRAIL-R1 mAb (TRM-1; HGS-ETR1)
  • Rochester, Minnesota
  • +6 more
Aug 1, 2013

Tumors by Site, Lymphoma, Non-hodgkin, Hodgkin Disease Trial in United States (PCI-24781)

Completed
  • Neoplasms by Site
  • +4 more
  • Greenbrae, California
  • +3 more
Sep 26, 2011

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3

Terminated
Has Results
  • Hodgkin Disease
  • +3 more
  • Leuprolide acetate depot (LAD) 11.25 mg 3 Month
  • Matched placebo
  • Saint Louis, Missouri
  • +3 more
Apr 9, 2010

Lymphoma, Non-Hodgkin, Hodgkin's Lymphoma Trial in United States (ABT-510 - Thrombospondin-1 Mimetic)

Completed
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Lymphoma
  • ABT-510 - Thrombospondin-1 Mimetic
  • Phoenix, Arizona
  • +13 more
Aug 13, 2007